Offline mode

Dehydroepiandrosterone (DHEA) Saliva ELISA

Catalog no.RE52651
Regulatory Status
RUO
Kit size
12 x 8
Method
ELISA
Incubation time
1 x 2 h, 1 x 30 min
Standard range
20 - 2160 pg/ml
Specimen / Volumes
50 µL saliva
Substrate / isotope
TMB 450 nm
instructions for usecertificateMSDS

Enzyme immunoassay for the quantitative determination of Dehydroepiandrosterone (DHEA) in human saliva. For research use only. Not for use in diagnostic procedures.

The IBL International DHEA ELISA Kit is a solid phase enzyme-linked immunosorbent assay (ELISA), based on the principle of competitive binding. The microtiter wells are coated with a polyclonal antibody directed towards an antigenic site on the DHEA molecule. Endogenous DHEA of a patient sample competes with a DHEA-horseradish peroxidase conjugate for binding to the coated antibody. After incubation the unbound conjugate is washed off. The amount of bound peroxidase conjugate is inversely proportional to the concentration of DHEA in the sample. After addition of the substrate solution, the intensity of colour developed is inversely proportional to the concentration of DHEA in the patient sample.

For concrete data please consult the Instruction for Use in the download box on the top right side.

  1. Thomas, L. (2012). Labor und Diagnose: Indikation und Bewertung von Laborbefunden für die medizinische Diagnostik, Frankfurt/Main: Th-Books Verl.
  2. Stanczyk, F. Z. (2009). Production, clearance, and measurement of steroid hormones. Glob Libr Women's Med, 1-19.
  3. Kamin, H. S., & Kertes, D. A. (2017). Cortisol and DHEA in development and psychopathology. Hormones and behavior, 89, 69-85.
  4. Quinn, T. A., Robinson, S. R., & Walker, D. (2018). Dehydroepiandrosterone (DHEA) and DHEA sulfate: roles in brain function and disease. Sex Hormones in Neurodegenerative Processes and Diseases, 41.
  5. Wood, P. (2009). Salivary steroid assays–research or routine?. Annals of clinical biochemistry, 46(3), 183-196
  6. Heaney, J. L., Phillips, A. C., & Carroll, D. (2012). Ageing, physical function, and the diurnal rhythms of cortisol and dehydroepiandrosterone. Psychoneuroendocrinology, 37(3), 341-349.
  7. Shoback, D., & Gardner, D. G. (Eds.). (2018). Greenspan's basic & clinical endocrinology. McGraw-Hill Education.
  8. Witchel S.F., Plant T.M. (2019) Puberty: Gonadarche and Adrenarche. Yen & Jaffe's Reproductive Endocrinology. 8th Edition. PART 2 Pathophysiology and Therapy. CHAPTER 18. 377-421.
  9. Guilliams, T. G., & Edwards, L. (2010). Chronic stress and the HPA axis. The standard, 9(2), 1-12.
  10. Bieger, W. P. (2015). Diagnostik der Steroidhormone im Speichel. OM & Ernährung. Nr. 152.
  11. Mihailescu (2012). A. Salivary biomarkers in stress research.
  12. Izawa, S. et al., (2008). Salivary dehydroepiandrosterone secretion in response to acute psychosocial stress and its correlations with biological and psychological changes. Biological psychology, 79(3), 294-298.
  13. Gill, J., Vythilingam, M., & Page, G. G. (2008). Low cortisol, high DHEA, and high levels of stimulated TNF‐α, and IL‐6 in women with PTSD. Journal of Traumatic Stress: Official Publication of The International Society for Traumatic Stress Studies, 21(6), 530-539.
  14. El Gharib, M. N., & Hazaa, S. E. D. (2014). Salivary versus serum approaches in assessment of biochemical hyperandrogenemia. Journal of Basic and Clinical Reproductive Sciences, 3(1), 54-57.
  15. Lindheim, L., Bashir, M., Münzker, J., Trummer, C., Zachhuber, V., Pieber, T. R., ... & Obermayer-Pietsch, B. (2016). The salivary microbiome in polycystic ovary syndrome (pcos) and its association with disease-related parameters: a pilot study. Frontiers in microbiology, 7, 1270.
  16. Tock, L., Carneiro, G., Pereira, A. Z., Tufik, S., & Zanella, M. T. (2014). Adrenocortical production is associated with higher levels of luteinizing hormone in nonobese women with polycystic ovary syndrome. International journal of endocrinology, 2014

Our Product Families

Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.

And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms.

All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use. 

All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).

Image on background

This is who we are.

As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.

Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.

Happy to help.

At Tecan, we are driven to improve people’s lives and health.